All News

The FDA accepted an investigational new drug application for chemo-related neuropathy, advancing a potential non-opioid treatment into a clinical trial.

The OPTIMAL trial finds oral DHP107 is as effective as IV paclitaxel for patients with advanced breast cancer while reducing side effects like neuropathy.

Elraglusib plus chemotherapy doubled one-year survival in metastatic pancreatic cancer, showing improved outcomes in a phase 2 trial.

A 30-year study reveals one in six AYA cancer survivors develop a new primary neoplasm, with risks highest for breast and oral cancer survivors.

Before my daughter was diagnosed with breast cancer, the “M” word was not a part of my vocabulary.

PDS01ADC showed high response rates in metastatic colorectal cancer in a phase 2 trial after prior treatment.

After an aggressive breast cancer diagnosis, psychologist Loraine Alderman retires to bridge gaps in patient literature through powerful advocacy.

Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions.

Dr. W. Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual disease

Emactuzumab improved tumor response and function in TGCT, showing rapid, durable benefits in a phase 3 trial with a short-course treatment approach.

Dr. Costas Bizekis discusses how minimally invasive surgery is improving recovery, reducing complications and enhancing outcomes in esophageal cancer.

Stage 1 urothelial carcinoma is highly treatable; learn about diagnosis, treatment options and how to reduce recurrence risk through ongoing monitoring.

Meetings like SGO drive collaboration and patient-centered progress, as Dr. Ginger J. Gardner highlights their role in advancing access and research.

Persistent heartburn may signal more than GERD. Learn how reflux can lead to Barrett’s esophagus and increase esophageal cancer risk.

April is Testicular Cancer Awareness Month. Join me this month raising awareness among young men ages 15 to 35 of one the handful of cancers that impacts men before adulthood.

Rezatapopt shows activity in TP53-mutated ovarian cancer, with responses seen across heavily pretreated patient groups and manageable side effects.

Daraxonrasib improved overall survival versus chemotherapy in metastatic pancreatic cancer.

A leukemia survivor shares how her experience inspired a national support network for young adults navigating cancer and survivorship.

Dr. Kemi Doll reports that peer support helped Black women with high-risk endometrial cancer complete treatment in the SISTER trial.

Gynecologic oncology is evolving beyond surgery, with greater focus on systemic therapies, team-based care and improved patient outcomes.

Real-world data show ADCs benefit more diverse, older and pretreated patients, helping guide care and build confidence beyond limited clinical trial populations.

Treatment with Verzenio and letrozole may help control advanced or recurrent endometrial cancer for some patients, according to new research.

Learn what an invasive breast cancer diagnosis means and explore treatment options, including surgery and targeted therapy, in this patient education guide.

An expert highlights global barriers to cancer care and outlines solutions to improve access, education and equity for patients worldwide.

Dr. Sheri Prentiss shares how early detection and patient advocacy can prevent chronic lymphedema and improve quality of life for cancer survivors.

An oncology social worker discusses the unique psychosocial challenges younger adults face during cancer treatment and survivorship.